» Articles » PMID: 10523208

Prospects for in Utero Human Gene Therapy

Overview
Journal Science
Specialty Science
Date 1999 Oct 16
PMID 10523208
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Gene therapy for the treatment of disease in children and adults is being actively pursued at many medical centers. However, a number of genetic disorders result in irreversible damage to the fetus before birth. In these cases, as well as for those with genetic diseases who may benefit from therapy before symptoms are manifested, in utero gene therapy (IUGT) could be beneficial. Although some successes with in utero gene transfer have been reported in animals, significant questions remain to be answered before IUGT clinical trials would be acceptable. This review analyzes the state of the art and delineates the studies that still need to be performed before it would be appropriate to consider human IUGT.

Citing Articles

Prenatal gene editing for neurodevelopmental diseases: Ethical considerations.

Major R, Juengst E Am J Hum Genet. 2025; 112(2):201-214.

PMID: 39879986 PMC: 11866956. DOI: 10.1016/j.ajhg.2025.01.003.


Placental Gene Therapy for Fetal Growth Restriction and Preeclampsia: Preclinical Studies and Prospects for Clinical Application.

Majumder S, Moriarty K, Lee Y, Crombleholme T J Clin Med. 2024; 13(18).

PMID: 39337133 PMC: 11432969. DOI: 10.3390/jcm13185647.


Hydrogel armed with Bmp2 mRNA-enriched exosomes enhances bone regeneration.

Yang Z, Li X, Gan X, Wei M, Wang C, Yang G J Nanobiotechnology. 2023; 21(1):119.

PMID: 37020301 PMC: 10075167. DOI: 10.1186/s12951-023-01871-w.


Intrauterine Fetal Gene Therapy: Is That the Future and Is That Future Now?.

Peddi N, Marasandra Ramesh H, Gude S, Gude S, Vuppalapati S Cureus. 2022; 14(2):e22521.

PMID: 35371822 PMC: 8951626. DOI: 10.7759/cureus.22521.


Will CRISPR Germline Engineering Close the Door to an Open Future?.

Mintz R, Loike J, Fischbach R Sci Eng Ethics. 2018; 25(5):1409-1423.

PMID: 30357560 DOI: 10.1007/s11948-018-0069-6.